Read article—Features Michael Cole, a professor of molecular and systems biology, in an article on new approaches to targeting MYC, a cancer-driving protein long considered "undruggable." The article reports that Cole is investigating compounds that could block MYC's ability to activate genes involved in tumor growth following a breakthrough pancreatic cancer trial targeting RAS proteins.